The Kidney Cancer SPORE of Dana Farber/Harvard Cancer Center, under the leadership of Drs. David McDermott and William Kaelin, seeks applications for the Career Enhancement Program in Kidney Cancer Research. Eligible candidates are those who are in their final year of clinical fellowship or postdoctoral fellowship (MD, PhD or MD/PhD required) or within their first 3 years on staff. A prior track record in kidney cancer research is preferred but not required. The awardee will receive up to two years of funding at up to $50,000 per year (exclusive of F&A costs), which can be used for salary and/or support of research at Harvard Medical School, the Harvard T. H. Chan School of Public Health, or any of the Harvard-affiliated hospitals. Funding sources may include Kidney Cancer SPORE (P50CA101942-13), corporate, and sundry monies. Depending on the source of funding for each award, awarded F&A will vary from 10% to your DHHS institutional negotiated rate. Therefore, we ask that F&A NOT be included in the requested budget and that applications must have institutional sign-off. Funding provided needs to be spent within the budgeted time period. Proposals should present a two year research plan with clearly defined milestones. Applicants will be evaluated using the 5 point NIH scale according to the following criteria-
- The scientific merit/quality of the proposal (coherent presentation, candidate's own work, kidney cancer focus, translational nature)
- The quality of the candidate (quality of previous work, potential for academic career in kidney cancer)
- The quality of the research environment (mentor support and track record, resources available)
Consideration will also be given to investigators expressing interest in shifting their research focus to kidney cancer. In this instance, items that will also be considered include:
- The seriousness of the commitment to translational research in kidney cancer
- The willingness of the individual to continue a productive relationship with the SPORE and the Kidney Cancer Program
The awardee will be expected to become a member of the DF/HCC Kidney Cancer Program and participate in Program activities including monthly research conferences, yearly half-day seminars, and the annual retreat. Women and minority candidates are encouraged to apply. Applications should be sent electronically to Tara Johnston, Program Administrator, at email@example.com, no later than 9 am on 8/4/17.
Applications must contain the following components using the PHS 398 forms:
- Cover* with Institutional Approval (Statement of Intent if outside BIDMC)
- Abstract of proposed research
- Research Proposal: Includes 1) Specific Aims, 2) Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages, exclusive of the proposed milestones and literature cited
- Applicants Career Goals (1 page)
- Research and Environment for proposed research
- Mentor(s) Letter of Support
- Applicant’s and Mentor’s current NIH Biosketch
- Applicant’s and Mentor's NIH Other Support Page
- Proposed Budget NIH 398 form: must not exceed $50,000/year (exclusive of F&A). Funds cannot be used for the purchase of any large equipment.
- Budget Justification
- NIH checklist for Institution rate
- IRB/IACUC approval documents (if applicable)
- Human Subject Training Certificate (if applicable)
*Please include Title, PI, and research administrator contact on cover sheet and submit all documents as one pdf file. Pages should be numbered.
Anticipated Award Dates: 09/01/17 – 08/31/18
We anticipate being able to support 1-2 projects for that period.